Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract 1155: Chemoresistance acquisition by ovarian adenocarcinoma cells due to microenvironment

Benoit Thibault, Magali Castells, Delphine Mihas, Ludivine Genre, Cecile Gandy, Eliane Mery, Jean Pierre Delord, Bettina C. Couderc

Cancer Res (2014) 74 (19_Supplement): 1155.

https://doi.org/10.1158/1538-7445.AM2014-1155

Published: 01 October 2014

View article titled, Abstract 1155: Chemoresistance acquisition by ovarian adenocarcinoma cells due to microenvironment

Journal Articles

Abstract 1535: Hospicells (MSCs and TAFs relative cells) activate ovarian carcinoma cells and macrophages to secrete IL-6, IL-8 and VEGF and polarize macrophages into a TAM phenotype.

Benoît Thibault, Magali Castells, Eliane Mery, Jean Pierre Delord, Bettina Couderc

Cancer Res (2013) 73 (8_Supplement): 1535.

https://doi.org/10.1158/1538-7445.AM2013-1535

Published: 15 April 2013

View article titled, Abstract 1535: Hospicells (MSCs and TAFs relative cells) activate ovarian carcinoma cells and macrophages to secrete IL-6, IL-8 and VEGF and polarize macrophages into a TAM phenotype.

Journal Articles

Abstract 5105: Genetic alterations of the metastatic lesions in ovarian carcinoma

Joel Malek, Eliane Mery, Binu George, Alejandra Martinez, Jean-Paul Thiery, Ruby Huang, Denis Querleu, Arash Rafii

Cancer Res (2012) 72 (8_Supplement): 5105.

https://doi.org/10.1158/1538-7445.AM2012-5105

Published: 15 April 2012

View article titled, Abstract 5105: Genetic alterations of the metastatic lesions in ovarian carcinoma

Journal Articles

Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

Emilie Bousquet, Julien Mazières, Maud Privat, Virginie Rizzati, Anne Casanova, Adeline Ledoux, Eliane Mery, Bettina Couderc, Gilles Favre, Anne Pradines

Cancer Res (2009) 69 (15): 6092–6099.

https://doi.org/10.1158/0008-5472.CAN-08-4147

Published: 29 July 2009

View article titled, Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

Includes: Supplementary data

Journal Articles

Pre-clinical rationales for Trastuzumab use in ovarian carcinoma in situation of minimal residual disease

Jean Pierre Delord, Cuider Allal, Philippe Rochaix, Eliane Mery, Isabelle Hennebelle, Diane Balin, Etienne Chatelut, Roland Bugat, Pierre Canal

Cancer Res (2004) 64 (7_Supplement): 1185.

Published: 01 April 2004

View article titled, Pre-clinical rationales for Trastuzumab use in ovarian carcinoma in situation of minimal residual disease

NARROW

Abstract 1155: Chemoresistance acquisition by ovarian adenocarcinoma cells due to microenvironment

Abstract 1535: Hospicells (MSCs and TAFs relative cells) activate ovarian carcinoma cells and macrophages to secrete IL-6, IL-8 and VEGF and polarize macrophages into a TAM phenotype.

Abstract 5105: Genetic alterations of the metastatic lesions in ovarian carcinoma

Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

Pre-clinical rationales for Trastuzumab use in ovarian carcinoma in situation of minimal residual disease

Email alerts

AACR Journals

Abstract 1155: Chemoresistance acquisition by ovarian adenocarcinoma cells due to microenvironment

Abstract 1535: Hospicells (MSCs and TAFs relative cells) activate ovarian carcinoma cells and macrophages to secrete IL-6, IL-8 and VEGF and polarize macrophages into a TAM phenotype.

Abstract 5105: Genetic alterations of the metastatic lesions in ovarian carcinoma

Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

Pre-clinical rationales for Trastuzumab use in ovarian carcinoma in situation of minimal residual disease

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only